The Oncology Institute Inc. (TOIIW)
Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 05
+0
+0.6316%
Pre Market
$
+0.01 +19.6653% 0. 06
4.93M Market Cap
- P/E Ratio
- Div Yield
15,216 Volume
0 Eps
$ 0.05
Previous Close Investors:
Want to track TOIIW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
TOIIW closed today higher at $0.05, an increase of 0.6316% from yesterday's close, completing a monthly decrease of -13.0909% or -$0.01. Over the past 12 months, TOIIW stock lost -63.2308%.
TOIIW is not paying dividends to its shareholders.
The last earnings report, released on Mar 12, 2026, exceeded the consensus estimates by 0.09%. On average, the company has surpassed earnings expectations by 0.09%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
The Oncology Institute Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 6,028 | $723.01 | $301.4 | -$421.61 | -58.31% |
The Oncology Institute Inc. (TOIIW) FAQ
What is the stock price today?
The current price is $0.05.
On which exchange is it traded?
The Oncology Institute Inc. is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is TOIIW.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 4.93M.
Has The Oncology Institute Inc. ever had a stock split?
No, there has never been a stock split.
The Oncology Institute Inc. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Daniel Virnich CEO | NASDAQ (CM) Exchange | 68236X118 CUSIP |
| US Country | 825 Employees | - Last Dividend | - Last Split | 4 Jun 2020 IPO Date |
Overview
The Oncology Institute, Inc. is a specialized oncology company based in the United States, known for providing comprehensive medical oncology services. Founded in 2007 and headquartered in Cerritos, California, the institute is dedicated to offering a wide range of oncology care, including advanced treatments and supportive services for cancer patients. The company's approach integrates innovative therapies and patient support programs to ensure holistic care for those battling cancer.
Products and Services
The Oncology Institute, Inc. offers a variety of oncology services designed to meet the comprehensive needs of cancer patients:
- Physician Services: The institute boasts a team of experienced oncology professionals providing expert diagnosis, treatment planning, and ongoing management of cancer.
- In-house Infusion and Dispensary: Patients have access to in-house infusion services for chemotherapy and other medications, along with a dispensary for necessary prescriptions, offering convenience and integrated care.
- Clinical Trial Services: The Oncology Institute leads and manages clinical trials, offering patients access to cutting-edge treatments and therapies under professional supervision.
- Outpatient Stem Cell Transplants and Transfusions Programs: These programs offer advanced treatments for suitable candidates, providing critical services in a patient-centered, outpatient setting.
- Patient Support: Recognizing the challenges that come with a cancer diagnosis, the institute provides comprehensive support services aimed at improving the quality of life for patients and their families.
Contact Information
Address: 18000 Studebaker Road
Phone: 213 760 1328
Website: https://theoncologyinstitute.com
